Vitasora Health Limited
VHLUF
$0.0581
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 304.00K | 312.60K | 102.00K | 101.80K | 48.00K |
| Total Other Revenue | 199.20K | 204.80K | 0.00 | 0.00 | 189.50K |
| Total Revenue | 503.10K | 517.40K | 102.00K | 101.80K | 237.60K |
| Cost of Revenue | 98.90K | 101.70K | -100.00 | -100.00 | 1.30K |
| Gross Profit | 404.20K | 415.60K | 102.00K | 101.80K | 236.20K |
| SG&A Expenses | 1.55M | 1.59M | 1.39M | 1.38M | 1.20M |
| Depreciation & Amortization | 9.80K | 10.00K | -8.30K | -8.30K | 29.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.69M | 1.74M | 1.40M | 1.40M | 1.26M |
| Operating Income | -1.19M | -1.22M | -1.30M | -1.30M | -1.02M |
| Income Before Tax | -1.19M | -1.22M | -1.30M | -1.30M | -1.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.19M | -1.22M | -1.30M | -1.30M | -1.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.19M | -1.22M | -1.30M | -1.30M | -1.04M |
| EBIT | -1.19M | -1.22M | -1.30M | -1.30M | -1.02M |
| EBITDA | -1.18M | -1.21M | -1.30M | -1.28M | -989.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.21B | 1.21B | 1.13B | 1.13B | 905.57M |
| Average Diluted Shares Outstanding | 1.21B | 1.21B | 1.13B | 1.13B | 905.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |